PharmaTimes - October 2015

News

News ReviewCDF shake-up / GPs and pharma’s growing divide / Dead end for off-patent drugs bill / Pharma’s transparency drive

SmartViews

Education, education, educationPharma has a crucial role in providing medical education, but must be fully transparent

Rise of the machinesArtificial intelligence is the key to smarter procurement and cost savings

Medical devices under the microscopeMedical devices could soon come under increased scrutiny as the EU’s new regulation proposals enter final discussions

Power trip Pharma companies in a dominant market position need to be sure they are not abusing their position or risk the consequences

Battle of the PacificWhat the Trans-Pacific trade deal means for pharma

SmartDealsRecent trends in pharma M&A / Pfizer in talks to acquire Allergan / AstraZeneca snaps up ZS Pharma / Shire buys potential competitor Dyax

Features

Taking a breathPharma’s role in tackling the challenges of Chronic Obstructive Pulmonary Disease

Voyage of rediscoveryRepurposing drugs can be a quick, inexpensive solution to diseases, but pharma has to be careful when repricing older medicines

People

SmartPeopleUniphar’s Padraic Dempsey on the healthcare industry in the UK and Ireland

MoversThis month’s job moves and new appointments

49 PatientFiles

COPD patient Joan McCarthy says that pharma could do more to educate COPD patients

Business Insight

ZenopaIt only takes one applicant to fill a job

October 2015 - magazine highlights

No items found